PXD064421 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Histone PTM analysis in breast cancer cells treated with methyltransferase inhibitors |
| Description | Histone PTM analysis were analyzed in breast cancer cells treated with methyltransferase inhibitors. |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-08-01 |
| AnnouncementXML | Submission_2025-08-01_03:11:07.144.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Roberta Noberini |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
| ModificationList | monomethylated residue; N6; acetylated residue; dimethylated residue |
| Instrument | Q Exactive Plus |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-05-29 10:27:17 | ID requested | |
| ⏵ 1 | 2025-08-01 03:11:07 | announced | |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: histone post-translationa modifications, methyltransferase inhibitors |
Contact List
| Tiziana Bonaldi |
| contact affiliation | European Institute of Oncology, Milan, Italy |
| contact email | tiziana.bonaldi@ieo.it |
| lab head | |
| Roberta Noberini |
| contact affiliation | Istituto Europeo di Oncologia |
| contact email | roberta.noberini@ieo.it |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/08/PXD064421 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD064421
- Label: PRIDE project
- Name: Histone PTM analysis in breast cancer cells treated with methyltransferase inhibitors